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The generation of induced pluripotent stem cells (iPSCs) by the forced expression of defined transcription
factors in somatic cells holds great promise for the future of regenerative medicine. However, the initial
reprogramming mechanism is still poorly understood. Here we show that Zscan4, expressed transiently in
2-cell embryosandembryonicstemcells(ESCs), efficientlyproducesiPSCsfrommouseembryofibroblasts
when coexpressed with Klf4, Oct4, and Sox2. Interestingly, the forced expression of Zscan4 is required only
for the first few days of iPSC formation. Microarray analysis revealed transient and early induction of
preimplantation-specific genes in a Zscan4-dependent manner. Our work indicates that Zscan4 is a
previously unidentified potent natural factor that facilitates the reprogramming process and reactivates
early embryonic genes.
S
omatic cells have been reprogrammed to the pluripotent state by nuclear transfer (NT), in which asomatic
nucleus is exposed to many unknown reprogramming factors that are thought to be present in oocytes,
zygotes, and 2-cell embryos
1–4. More recently, somatic cells have been reprogrammed to become induced
pluripotentstemcells(iPSCs)byexposingasomaticnucleustothedefinedsetoftranscriptionfactors:Myc,Klf4,
Oct4 (official gene symbol: Pou5f1), and Sox2 in the original formulation
5; other factors including transcription
factors, small molecules, and microRNAs in the newer formulation (reviewed in
6–9).
Although both procedures produce pluripotent cells that can give rise to live offspring by injection into mouse
blastocysts, they seem to exhibit notable differences. For example, it has been suggested that the reprogramming
of somatic cells by NT occurs within a few cell divisions
10, whereas the reprogramming of somatic cells into
murine iPSCs requires about 1–2 weeks of continuous application of factors for at least the first 8–10 days
11.
Whole-genome DNA methylation analyses have indicated that murine pluripotent stem cells made by the iPSC
procedure retain an epigenetic memory of donor somatic cells, which is not apparent in pluripotent stem cells
made bythe NTprocedure
12.Furthermore, it hasbeen reported thatthe genomeintegrity ofhuman iPSCsseems
to be often compromised with mutations and genome alterations
13–17. Accordingly, the efficient production of
high-quality iPSCs may become feasible by factors that can make the reprogramming process similar to that
whichoccursduringtheNTprocedure
18.Asafirststep,itisdesirabletofindafactorthatcanreactivategenesthat
are expressed in preimplantation embryos, i.e., NT environment, during iPSC generation.
Previously, we have shown that Zscan4 (zinc finger and SCAN domain containing 4), expressed specifically in
2-cellembryos andonlyabout5%of ESCsatagiventime
19,acts criticallyintheformation ofproper blastocysts
19
andinthemaintenanceofgenomestabilityandtelomeresinESCs
20.Accordingly,wehypothesizedthatZscan4is
a factor that is present in the NT environment, but is missing in the current repertoire of iPSC factors. Here we
have tested this notion and demonstrated that Zscan4 indeed functions as a potent enhancer of the reprogram-
ming process in iPSC formation.
Results
Zscan4 is reactivated in late-stage iPSCs. To investigate whether Zscan4 is reactivated during iPSC formation,
wefirstgeneratedmouseESCscarryinganEmerald(aGFPvariant)reporterdrivenbya3.5 kbZscan4promoter,
whichcanreproducetheexpressionpatternofendogenousZscan4inmouseESCs
20.Chimericmiceproducedby
injecting the ESCs (named ES-pZ-Emerald) into blastocysts were used to generate E13.5 embryos, which were
SUBJECT AREAS:
STEM CELLS
CELL BIOLOGY
DEVELOPMENTAL BIOLOGY
REPRODUCTIVE BIOLOGY
Received
30 August 2011
Accepted
12 December 2011
Published
4 January 2012
Correspondence and
requests for materials
should be addressed to
M.S.H.K. (kom@mail.
nih.gov)
SCIENTIFIC REPORTS | 2 : 208 | DOI: 10.1038/srep00208 1subsequently used to derive mouse embryo fibroblasts (MEFs). The
MEFs in which the presence of an Emerald reporter was confirmed
bygenotypingwerenamedMEF-pZ-Emeraldcells(Fig.1a).Emerald
fluorescence was not detectable in the MEF-pZ-Emerald cells, in-
dicating that Zscan4 is not expressed in MEFs.
We then transfected a piggyBac vector (PB-TET-MKOS)
21,22 car-
ryingdoxycycline (Dox)-inducible Myc(M),Klf4(K),Oct4(O),and
Sox2 (S), into the MEF-pZ-Emerald cells, and then cultured the cells
in ESC media supplemented with Dox. As reported, colonies with
an authentic ESC-like morphology were clearly visible by day 13
(Fig. 1b). We observed the cells under fluorescence microscopes
daily, but did not find any Emerald1 cells in culture. We picked
28 ESC-like colonies and passaged them into ESC culture media
without Dox 11 to 14 days after the piggyBac transfection. Two
clones did not survive, but the other 26 clones proliferated to form
ESC-like colonies. Colonies with Emerald1 cells began to appear
from day 15 and by day 28 all the colonies showed the presence of
Emerald1 cells in the same pattern as typical F1 hybrid ESC lines: a
small number (1.060.5%, S.E.M.) of Emerald1 cells (Fig. 1c, 1d).
The data indicate that iPSCs, once formed, gained the expression
pattern of Zscan4 similar to ESCs, suggesting a close similarity be-
tween iPSC and ESCs. Importantly, Zscan4 was not activated during
the early phase of iPSC formation by the MKOS factors. Consistent
with this finding, reanalysis of the published microarray data
23–25did
not reveal the activation of Zscan4 during the early phase of iPSC
formation.
The data also indicate that, as reported previously
21,22, the produc-
tion of iPSC by a piggyBac vector carrying MKOS factors was robust
and the majority (26 of 28) of ESC-like colonies indeed became
authentic iPSCs, as confirmed by the same unique expression pattern
of Zscan4 as typical ESCs. This notion was further supported by
the presence of a pluripotency marker NANOG
26 (Supplementary
Fig. S1a, S1b), which was not used as an exogenous iPSC factor, and
the expression of a GFP marker under the control of the Oct4 pro-
moter
27 (Supplementary Fig. S1c) in the ESC-like colonies generated by
the PB-TET-MKOS. Therefore, in subsequent experiments, we prim-
arily used the ESC-like colony morphology combined with alkaline
phosphatase staining (ALP1) to score the number of authentic iPSCs.
Figure 1 | Zscan4isnotexpressedduringearlyphaseofiPSCformation,butreactivatedlateriniPSCcells. (a)Schematicrepresentationofprocedures
toexamineZscan4expressionduringiPSCformation.TA1ESCs,F1hybridstrain(C57BL/6Jx129S6/SvEvTac).ApiggyBactransfectioninvolvesamain
vectorPB-TET-MKOS(shown),PB-CAG-rtTA(atetracyclinetransactivator),andpCyL43(transposase).(b)Phase-contrastmicroscopicimagesduring
theformationofcellcolonieswithauthenticES-likemorphology.Day0issetwhendoxycycline(Dox)isaddedtothecompleteESmedium24 hoursafter
a piggyBac transfection. (c) Fluorescence images (left), fluorescence images merged with phase-contrast images (middle), and flow cytometry charts
(right) of two representative cell clones established from ESC-like colonies and cultured in the absence of Dox. (d) Appearance of Emerald1 cells
(represented as ‘‘1’’) in the culture. Fraction of Emerald1 cells was measured by the flow cytometry on day 28.
www.nature.com/scientificreports
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effects of exogenous Zscan4 overexpression on iPSC formation,
we cotransfected PB-TET-MKOS with either PB-TET-DsRed
(control), PB-TET-Zscan4c, or PB-TET-Zscan4-ERT2 into wild-
type MEF cells (MEF-WT) (Fig. 2a). The PB-TET-Zscan4-ERT2
was made by fusing Zscan4c to ERT2 (a mutated ligand-binding
domain of the human estrogen receptor, which can be activated by
the presence of tamoxifen [Tmx])
28 (Fig. 2a). We found that Zscan4
increased the number of ALP1 ESC-like colonies by about 1.5-fold
compared to the DsRed control (Fig. 2b, 2c; see also Supplementary
Fig. S1d for the NANOG1 assay and Supplementary Fig. S1e for the
Oct4-GFP assay). We also found that the human ZSCAN4 gene
functions similarly to mouse Zscan4 in mouse iPSC formation
(Supplementary Fig. S2a, S2b). As expected, the cotransfection of
PB-TET-Zscan4-ERT2 increased the number of ALP1 ESC-like
colonies only in the Tmx1 condition (Fig. 2b, 2c). When these
ESC-like colonies, made with or without Zscan4 contribution, were
picked and passaged onto regular ESC culture conditions (Dox-
Tmx-), most (18 of 24) of them proliferated to form ESC-like
colonies, which were confirmed to be authentic iPSCs by the ex-
pression of endogenous pluripotency markers (Oct4, Sox2, Nanog,
Rex1, and Dax1), ALP-staining, embryoid body (EB) formation, and
the ability to differentiate into cells of three germlayers (Fig. 2d–2k).
Taken together, Zscan4 can enhance the efficiency of MKOS-
mediated iPSCs formation. The results also indicate that Zscan4-
ERT2 can be used as a Tmx-controllable Zscan4 factor. Therefore,
in the subsequent analysis, we used the Zscan4-ERT2.
To facilitate the analysis of Zscan4-aided iPSC formation, we gen-
erated ESCs (named ES-ZERT), in which mouse Zscan4c fused to
ERT2wasconstantlyexpressedunderastrongandubiquitousCAG-
promoter
29(Fig. 3a).The expression of Zscan4-ERT2 wasconfirmed
byqRT-PCR(SupplementaryFig.S3a).TheTmx1conditionslowed
Figure 2 | ForcedexpressionofexogenousZscan4increasestheefficiencyofiPSCformationfromthewild-typeMEFs. (a)Schematicrepresentationof
procedures to examine the effects of exogenous Zscan4 on iPSC formation from wild-type MEFs (C57BL/6J x 129S6/SvEvTac). (b) Representative
picturesof6-wellplatesstainedforALP14daysafterDox(andTmx-orTmx1)induction.(c)ColonieswithauthenticESCmorphologyandALP1were
scored. Transfections and Dox inductions were performed in triplicate. Data from two independent experiments are shown. Data are represented as
mean6S.E.M.(triplicatewells).*,P,0.01.(d)SeveralESC-likecolonieswerepicked,propagatedintheDox-condition,andestablishedascellclones:5
clones (MKOS factors: A2–A6) and 4 clones (MKOS factors 1 Zscan4). RT-PCR analysis of these clones with pluripotency gene markers: endogenous
Oct4,endogenousSox2,Nanog,Zfp42(Rex1),andDax1(Nr0b1).Gapdhwasusedasacontrol.ThecloneB5(MKOSfactors1Zscan4)wasusedforthe
subsequent analyses (e–g). (e) A representative image of ALP staining. (f) A microscopic image showing embryoid bodies (day 4) generated from the
clone. (g) Fluorescence microscopic images of the clone after in vitro differentiation from the embryoid body shown in (F), and stained with antibodies
against aSMA (mesoderm), AFP (endoderm), GATA4 (endoderm), and bIII-tubulin (ectoderm). Pictures (bottom) are the same images after merging
withDAPI-staining. Scalebar,100mm.(h–k)Thesame assayswereperformedon5clones(MKOSfactors1Zscan4-ERT2[Tmx-]: C1-C6)and4clones
(MKOS factors 1 Zscan4-ERT2 [Tmx1]: D2–D6). The clone D3 (MKOS factors 1 Zscan4-ERT2 [Tmx1]) was used for the detailed analyses (i–k).
www.nature.com/scientificreports
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dition did not (Supplementary Fig. S3b). Because the Tmx did not
affect the proliferation of wild-type ESCs (Supplementary Fig. S3b),
this result indicates that Zscan4 function can be turned on in ESCs
carrying a Zscan4-ERT2 construct in the presence of Tmx1. The
effect of Zscan4 on ESC proliferation was reversed within three days
when Tmx was removed from the media (Supplementary Fig. S3c,
S3d).MicroarrayanalysisalsoshowedthattheeffectofZscan4onthe
ESCtranscriptomemostlyrecededwithinthreedaysafterTmxwith-
drawal (Supplementary Fig. S3e – S3i). MEFs (MEF-ZERT) derived
from ES-ZERT (Fig. 3a, 3b) also showed slower proliferation in the
Tmx1 condition than in the Tmx- condition (Fig. 3c).
After transfecting a PB-TET-MKOS vector, the MEF-ZERT cells
and control MEF-WT cells were cultured with or without Tmx in
standard iPSC generation conditions (Dox1) (Fig. 3d). Scoring the
number of ALP1 ESC-like colonies after 14 days revealed that the
Tmx1 condition increased the number of iPSC colonies by 1.5- to
2-fold in the MEF-ZERT cells, whereas the Tmx1 condition did not
affect the efficiency of iPSC formation in the MEF-WT cells (Fig. 3e,
3f). These data further confirmed that the Tmx-controlled Zscan4-
ERT2 system works during iPSC formation and that Zscan4
enhances iPSC formation by MKOS factors.
When these ESC-like colonies were picked and transferred to
the Dox- Tmx- condition, most of the clones (9 of 12) made by both
Figure 3 | Zscan4 increases the efficiency of iPSC formation in Tmx-dependent manner from the Zscan4-ERT2-expressing MEFs. (a) A pCAG-
Zscan4cERT2vectorwastransfectedintoV6.5ESCs(C57BL/6x129/Sv)tomakeZscan4-ERT2ESCs(ES-ZERT).ES-ZERTcellsweremicroinjectedinto
blastocysts from ICR mice to generate male chimeric mice, which were subsequently mated with ICR female mice. E13.5 embryos were used to generate
mouse embryo fibroblasts (MEFs). MEFs were subjected to genotyping and quantitative RT-PCR. MEFs that carried pCAG-Zscan4cERT2 DNA and
expressed exogenous Zscan4c were designated as MEF-ZERT and MEFs that did not were designated as MEF-WT (wild type). (b) Zscan4 expression in
MEF-ZERTcelllinescomparedtothatinESCs.ExpressionlevelsofZscan4intwodifferentseriesofMEFs(A1–A13andB1–B11)wereexaminedbyqRT-
PCR.Dataintriplicatewererepresentedasmean6S.E.M.MEFlinesmarkedwith*wereusedinthiswork:MEF-ZERT(#A2,#A7,#B5);MEF-WT(#A3).
(c)GrowthcurvesofMEF-WTandMEF-ZERTculturedandpassagedinTmx1andTmx-conditions.(d)ApiggyBacvector(PB-TET-MKOS)carrying
doxycycline (Dox)-inducible Myc (M), Klf4 (K), Oct4 (O), and Sox2 (S), was transfected into MEF-ZERT and MEF-WT, respectively. The cells were
culturedundertheDox1Tmx-orDox1Tmx1conditionfor14days,fixed,andstainedforalkalinephosphatase(ALP).(e)Representativepicturesof6-
well plates stained for ALP. (f) ALP1 ESC-like colonies were scored (mean6S.E.M.). *,P, 0.05. (g) A representative phase-contrast image of an iPSC
clone derived from the MEF-ZERT (Tmx1) condition. (h) A representative image of the clone stained for ALP. (i) Fluorescence-microscopic images of
thecloneafterstainingwithantibodiesagainstSSEA-1andNANOG.Pictures(right)arethesameimagesaftermergingwithDAPI-staining.(j)Karyotype
analysis of iPSCs generated with MKOS (Tmx-: 5 independent clones) and ZMKOS (Tmx1: 8 independent clones) conditions. For each clone, the
fraction of cells with a normal karyotype (% euploid) was calculated based on more than 40 metaphase spreads. Then, mean 1 S.E.M. was calculated for
each group (P , 0.05). (k) A representative picture of live E13.5 embryos entirely generated from iPSC clone made with the ZMKOS.
www.nature.com/scientificreports
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(Dox1 Tmx- conditions) continued to proliferate without these
exogenous factors. Furthermore, the ZMKOS clones did not show
any difference from the MKOS clones in the standard tests for the
formation of authentic iPSCs, i.e., ALP-staining of colonies (Fig. 3g,
3h), immunohistochemistry of pluripotency markers (Fig. 3i), RT-
PCR analysis of pluripotency genes (Supplementary Fig. S4a), DNA
methylation patterns (Supplementary Fig. S4b), embryoid body
formation (Supplementary Fig. S4c), and ability to differentiate into
three germ layers (Supplementary Fig. S4d). However, karyotype
analysis of .40 metaphase spreads each from 5 independent
MKOS clones and 8 independent ZMKOS clones suggested that
iPSCs generated with ZMKOS seem to have better karyotypes than
thosemade with MKOS (Fig. 3j). Although an extensive comparison
was not done, we also found that the injection of iPSCs (ZMKOS)
into tetraploid (4N) blastocysts formed an entire mouse embryo
(Fig. 3k). As the embryos are entirely derived from iPSCs in the
tetraploid complementation system
30, the results demonstrated that
iPSCs generated with ZMKOS factors were fully pluripotent.
Zscan4 can replace Myc for the iPSC formation. Previous studies
have shown that oncogene Myc, which increases cell proliferation
and suppresses genome stability, is required for efficient iPSC
formation (reviewed in
31). To test whether Zscan4 can enhance
iPSC formation without Myc, we transfected MEF-WT and MEF-
ZERT cells with a PB-TET-KOS vector carrying Dox-inducible KOS
factors and cultured the cells in Dox1 Tmx1 or Dox1 Tmx- con-
ditions for 2 weeks (Fig. 4a). As expected, MEF-WT cells produced
only a small number of ALP1 ESC-like colonies (Fig. 4b). However,
MEF-ZERT cells produced 40- to 70-fold more ALP1 ESC-like
colonies in Dox1 Tmx1 (i.e., ZKOS) conditions than in the con-
trol Dox1 Tmx- (i.e., KOS) conditions (Fig. 4b). The result was
confirmed in independent experiments (Supplementary Fig. S5a,
S5b). When the ESC-like colonies were picked from the ZKOS
condition (i.e., Dox1 Tmx1) and cultured without the exogenous
factors (i.e., in the Dox- Tmx- condition), most of them (9 of 11)
proliferated to form authentic iPSCs judged by the RT-PCR analysis
of pluripotency genes (Supplementary Fig. S5c), the ALP-staining
of colonies (Supplementary Fig. S5d), embryoid body formation
(Supplementary Fig. S5e), ability to differentiate into three germ
layers (Supplementary Fig. S5f), and 4N complementation assay
(Supplementary Fig. S5g). The number of iPSC colonies generated
by ZKOS factors (Fig. 4b) was comparable to that generated by
MKOS factors (Fig. 2c, 3f). Thus, in combination with KOS
factors, Zscan4 can replace Myc for iPSC formation.
Zscan4 is required only for the first few days during iPSC forma-
tion. To further clarify the role of Zscan4 in reprogramming, we
examined when and how long Zscan4 is required. It has been
shown that efficient iPSC formation requires the ectopic over-
expression of MKOS factors for at least 8–10 days
11,24. Using a
Tmx-inducible system of Zscan4 expression in MEF-ZERT cells,
Figure 4 | Zscan4 enhances iPSC formation without Myc and is required only for the first few days of induction. (a) Schematic representation of
experimentalproceduresforiPSCgeneration.(b)Representativepicturesof6-wellplatesstainedforALP20daysaftertheDoxinduction.ALP1ESC-like
colonies were counted (mean6S.E.M.). *,P, 0.05. (c, d) Efficiency of iPSC formation was examined after different Tmx treatments. ALP1 ESC-like
colonies were counted 20 days after induction (mean6S.E.M.). Different letters denote statistically significant differences between groups (P , 0.05).
www.nature.com/scientificreports
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factors, we could vary the time of exposure to Zscan4 (Fig. 4a).
The absence of Tmx for the first 4 or 7 days significantly reduced
the number of iPSC colonies, whereas the presence of Tmx for only
the first 4 or 7 days was sufficient to produce a number of ALP1
ESC-like colonies comparable to that obtained by the presence of
Tmx for 20 days (Fig. 4c). Further experiments with progressive
shortening of exposure established that Tmx is required only for
the initial day of iPSC formation (Fig. 4d). As we showed above,
the addition of Tmx turned on Zscan4 effects within a day, whereas
the removal of Tmx turned off Zscan4 effects within 3 days. There-
fore, these data indicate that the forced expression of Zscan4 is
required only for the first few days, and can thus influence the
early phase of reprogramming.
Secondary MEF system further confirms that Zscan4 plays a
distinct role among iPSC factors. It has been shown that the
secondary MEF system facilitates the analysis of early events
leading to iPSC formation, because every cell carries inducible
iPSC factors
11,18,23. To generate secondary MEF cells, we first
cotransfected MEF-WT cells with PB-TET-KOS and PB-TET-
Zscan4-ERT2 vectors (Fig. 5a). After culturing these cells in Dox1
Tmx1 condition for 2 weeks, ESC-like colonies were picked and
propagated in the Dox- Tmx- condition. Clones #2 and #4 were
analyzed further and confirmed as authentic iPSC cells based on
the RT-PCR analysis of pluripotency genes (Fig. 5b), ALP-staining
of colonies (Fig. 5c, 5d), immunohistochemistry of pluripotency
markers (Fig. 5e), the formation of the embryoid body (Fig. 5f),
the ability to differentiate into three germ layers (Fig. 5g), and the
production of live embryos by 4N complementation assay (Fig. 5h).
These iPSCs also showed .80% normal karyotype and global
gene expression profiles indistinguishable from ESCs (Fig. 5i). The
E13.5 embryos generated from the iPSC (ZKOS#2) by the 4N
complementation assay were subsequently used to derive the
secondary MEFs (named MEF-KOS-ZERT
2nd) (Fig. 5a).
As expected, without ZKOS induction (i.e., Dox- Tmx- and Dox-
Tmx1 conditions), ALP1 ESC-like colonies were not formed from
the MEF-KOS-ZERT
2nd cells by day 17. By contrast, the forced
expression of ZKOS factors (Dox1 Tmx1 condition) produced a
large number (,400) of ALP1 ESC-like colonies, whereas the KOS
factor only (Dox1 Tmx- condition) produced a much smaller num-
ber (,20) of ALP1 ESC-like colonies (Fig. 5j). The Dox-dependent
expression of exogenous Zscan4-ERT2, Klf4, Oct4, and Sox2 were
confirmed by qRT-PCR (Fig. 5k). The upregulation of an endo-
genous Myc, which was not included as an exogenous iPSC factor,
was not observed (Fig. 5k). The secondary MEF system also showed
that Zscan4 is required only for the first few days of iPSC formation
(Supplementary Fig. S6a). By contrast, KOS factors were required
for at least the first 6 days (Supplementary Fig. S6b). These results
further provide independent confirmation of our aforementioned
observation that Zscan4 acts in the early phases of reprogramming
and plays a distinct role among iPSC factors.
Previous studies on the secondary MEFs using MKOS factors
on a piggyBac vector have shown that early morphological changes
of the MEFs, i.e., the mesenchymal-epithelial transition (MET), are
the important first step for iPSC formation
23. Interestingly, in our
system, both the KOS factors and the ZKOS factors caused dramatic
changes in MEF morphology by day 1: the cells became flatter and
lost the typical spindle-shape of MEFs (Fig. 5j). However, only the
ZKOS condition (i.e., Dox1 Tmx1 condition) produced ESC-like
colony structures by day 6, and resulted in a large number of iPSC
colonies by day 17 (Fig. 5j). These data thus indicate that the MET
is a feature that can be caused by KOS factors alone and does not
necessarily lead to iPSC formation, suggesting that the MET is not
sufficient for eventual iPSC formation.
Global expression profiles reveal the transient reactivation of
preimplantation-specific genes in a Zscan4-dependent manner.
Consistent with a dramatic morphological change, the forced
expression of KOS alone (Dox1 Tmx-) altered the transcriptomes
of MEF-KOS-ZERT
2nd significantly by day 1: upregulation of 1730
genes and downregulation of 947 genes (Fig. 6a, first row). By day 3
and 6, the number of expression-altered genes further increased.
However, considering that the KOS condition (Dox1 Tmx-)
produced only a small number of iPSCs after 17 days in culture
(Fig. 5j), these transcriptome alterations were not sufficient enough
to convert MEFs to iPSCs.
By contrast, a comparison between the iPSC-producing ZKOS
condition (Dox1 Tmx1) and the KOS condition (Dox1 Tmx-)
revealed only a minor transcriptome difference (Fig. 6a, fourth
row): 28 genes by day 1, 162 genes by day 3, and 237 genes by day
6. That such a small difference in transcriptome yielded such a great
differenceinthenumberofiPSCcolonieswasastounding,suggesting
the significance of these genes for Zscan4-mediated iPSC formation.
After combining lists of these genes, we obtained 231 distinct genes
that were more highly expressed in the ZKOS condition than in
the KOS condition (with the statistical significance of FDR#0.05,
fold-change$2) (Fig. 6a). For these 231 genes, the fold-differences
between Tmx1 (i.e., Zscan41) and Tmx- (i.e., Zscan4-) were calcu-
lated, subjected to hierarchical clustering, and presented as a heat-
map (Fig. 6b, Supplementary Table S1).
We noticed that some of these genes were originally identified
from only preimplantation embryos through large-scale cDNA
sequencing projects
32, e.g., Pramel6, D5Ertd577e, D13Ertd608e,
Tcstv1
33, Trim43a
34, and Trim43b
34. Accordingly, we searched the
public Expressed Sequence Tags (ESTs) database (NCBI/NIH) and
scoredthenumberofESThitsforeachgene.Asignificantfractionof
the 231 genes was indeed expressed predominantly in early embryos
and closely related gonads (testis and ovary): 27 genes in the pre-
implantation stage (1-cell – blastocysts); 14 genes in oocytes; and 37
genes in testis/ovary (Fig. 6b, Supplementary Table S2). The preim-
plantation- and gonad-specific expression of these genes was also
confirmed by the expression patterns in the NIA Gene Expression
Atlas
35 (Fig. 7a; Supplementary Fig. S6c) and the GNF database
36
(Fig. 7b; Supplementary Fig. S6d). Interestingly, most of these genes
showed little or no expression in MEFs, ESCs, and iPSCs (Fig. 7a;
Supplementary Fig. S6c), indicating that these genes are activated
transiently in the early phase of iPSC formation, but then down-
regulated once iPSCs are fully formed. These genes may thus re-
present the earliest markers for Zscan4-mediated iPSC formation
from MEFs, because they were fully activated as early as day 1, 3,
or 6, when typical pluripotency markers such as Nanog, Zfp42 (also
known as Rex1), and Dppa5a (also known as Esg1) were still silent
(Supplementary Fig. S7a).
The early activation of preimplantation-specific genes seems to be
uniquetoZscan4-mediatediPSCformation.Indeed,previousmicro-
array studies of the secondary MEF system using piggyBac MKOS
factors have not identified the activation of preimplantation-
specific genes as the critical features of iPSC-forming transcriptome
changes
23. For example, most of the 231 critical genes that we iden-
tifiedwerenotactivatedtransientlyduringtheearlyphaseofMKOS-
based iPSC formation (Supplementary Fig. S7b, S7c). These data
suggest that Zscan4-mediated iPSC formation takes a different
path from standard MKOS-mediated iPSC formation: the former
path is more strongly associated with the genetic program occurring
in the preimplantation embryos than the latter path.
Discussion
Previously, we have shown that Zscan4, which is not expressed
in blastocysts, is activated in a subpopulation of cells by day 6 during
the derivation of ES cells from blastocysts in vitro
19. We have also
shown that Zscan4 is transiently expressed in late 2-cell embryos
19,
www.nature.com/scientificreports
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ming activity in NT cloning experiments
4.I nt h i sp a p e r ,w en o w
show that Zscan4 is not expressed in the early phase of standard
MKOS-mediated iPSC formation, but begins to be expressed in a
subpopulation (1–5%) of iPSCs later, once they become mature
iPSCs. The results led to a hypothesis that Zscan4 can make the
reprogramming process similar to that which occurs during the
NT procedure and prompted us to examine the effects of forced
expression of Zscan4 on the process of iPSC formation. Our work
has established that Zscan4 is a potent early embryonic factor
with distinct properties that can help to reprogram MEFs to
iPSCs.
Figure 5 | Secondary MEFs derived from iPSCs can generate iPSCs without transfection in Zscan4-dependent manner. (a) iPSC colonies were
generated by transfecting MEF-WT (C57BL/6Jx129S6/SvEvTac) with piggyBac vectors (PB-TET-KOS and PB-TET-Zscan4ERT2-IRES-HisDsRed) and
culturing the cells for two weeks under the Dox1 Tmx1 condition. Under fluorescence microscope, Zscan4-ERT2
1 colonies could be identified by red-
fluorescence. The two red colonies were picked from the wells and propagated in the ES cell culture condition on feeder cells, resulting in the
establishment of two cell clones (#2, #4). (b) RT-PCR analysis of these clones and control MEF-WT cells with pluripotency gene markers. (c) A phase-
contrastimageoftheclone(ZKOS#2).(d)Aphase-contrastimageoftheclone(ZKOS#2)afterstainingwithALP.(e)Fluorescencemicroscopicimagesof
the clone (ZKOS#2) after staining with antibodies against SSEA-1 and NANOG. (f) A microscopic image showing embryoid bodies (day 4) generated
from the iPSC clone (ZKOS#2). (g) Fluorescence images of the clone (ZKOS#2) after in vitro differentiation from the embryoid body shown in (f), and
stainedwithantibodiesagainstaSMA,AFP,GATA4,andbIII-tubulin.Scalebar,100mm.(h)E13.5embryosderivedfromtheclone(ZKOS#2)bythe4N
complementation. These embryos were used to generate secondary MEFs (MEF-KOS-ZERT
2nd) asdescribed in(a). (i) Global expression profiles of cells
were generated by using DNA microarrays. (Upper Panel) A scatter-plot showing pair-wise comparison between the clone (ZKOS#2) and MEF-WT.
(LowerPanel)Ascatter-plotshowingpair-widecomparisonbetweentheclone(ZKOS#2)andV6.5ESC.Spotsincolorrepresentgeneswhoseexpression
showstatisticallysignificantdifferencesbetweensamples(FDR#0.05,fold-change$2)
45.(j)MorphologiesoftheMEF-KOS-ZERT
2ndcellsduringthefirst
6 days of Dox and Tmx treatments. Pictures of cells after ALP-staining on day 17 are also shown. (k) qRT-PCR analysis of the MEF-KOS-ZERT
2nd cells.
Expressionlevelsofgenesarepresentedasfold-differencecomparedtothoseinESCs.Resultsusingprimerpairsthatrecognize39-UTRofgenesrepresent
the expression levels of endogenous genes, whereas results using primer pairs that recognize the open reading frame (ORF) of genes represent the
combined expression levels of endogenous and exogenous (from the piggyBac vectors) genes.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 208 | DOI: 10.1038/srep00208 7Our work reveals a number of remarkable features of Zscan4 as a
reprogramming factor (Fig. 7c). First, Zscan4 action is fast, as it is
required only for the initial few days during the long process of iPSC
formation. It has been well established that the continuous presence
ofiPSC factorsforatleast 8–10daysor foratleast5 daysforMyc
24is
required for iPSC formation. Our own results by shortening Dox
exposure (i.e., overexpression of KOS factors) have also confirmed
these earlier results. Furthermore, unlike other iPSC factors, which
are expressed highly and rather homogeneously in ESCs, Zscan4 is
expressed in only a small fraction (1%–5%) of ESCs
19. Our earlier
analysis of systematically perturbing the transcriptomes of mouse
ESCs by overexpressing specific transcription factors showed that
Zscan4 belongs to regulatory modules distinct from Oct4, Sox2,
Nanog, and other core pluripotency TFs
37. It is also striking that
theoverexpressionofZscan4causesveryminorchangestothetrans-
criptomeduringtheearlyphaseofreprogramming,butmajordiffer-
ences to the outcome of iPSC formation. This is another indication
that the mode of Zscan4 action is quite different from other iPSC
factors. One could speculate that Zscan4 may be involved in epige-
netic regulation or chromatin remodeling: the overexpression of
such factors does not alter the transcriptome dramatically compared
to regular transcription factors
37.
Second, Zscan4-mediated reprogramming activates 231 genes in
MEFs in a Zscan4-dependent manner, which are rather specifically
expressed in preimplantation embryos, oocytes, and gonads, sug-
gestingthatZscan4isapotentinducerofthepreimplantationgenetic
program, including reprogramming activity. The data also hint at
the presence of a common mechanism between reprogramming
mediated by NT and reprogramming mediated by ZKOS for iPSC.
While this manuscript was being reviewed, a paper reporting that
Glis1,whichisexpressedinMetaIIoocytes,couldbeusedasarepro-
gramming factor that can replace Myc, was published
38. We checked
our microarray data and found that Glis1 was transiently upregu-
lated on day3 in both Dox1 Tmx- and Dox1 Tmx1 conditions,
Figure 6 | Microarray analysis reveals Zscan4-dependent activation of preimplantation- and gonads-specific genes during the early phase of iPSC
formationfromtheMEF-KOS-ZERT
2ndcells. (a)Scatter-plots showingpair-wisecomparisonbetweenDox1Tmx-(KOSfactors) andDox- Tmx-(No
factor); Dox1 Tmx1 (ZKOS factors) and Dox- Tmx1 (No factor); Dox- Tmx1 (No factor) and Dox- Tmx- (No factor); and Dox1 Tmx1 (ZKOS
factors) and Dox1 Tmx- (KOS factors) conditions. Cells were harvested on day 1, 3, and 6 after beginning the Dox or Tmx treatment. Figures in each
scatter plot represent the number of genes that showed statistically significant differences between the conditions (FDR#0.05, fold-change$2). A list of
non-redundant 231 genes were obtained by combining 12 (day 1), 90 (day 3), and 178 (day 6) genes that were more highly expressed in Dox1 Tmx1
(ZKOS)conditionthaninDox1Tmx-(KOS)condition.(b)Aheatmapshowingthefold-differenceofexpressionlevelsof231genesbetweenTmx1and
Tmx- conditions. The fold difference for each gene was calculated by dividing the expression level (Tmx1) by the expression level (Tmx-). Among 231
genes, Pramel6 showed the highest fold-difference: 10.2-fold on day 3 (see the Supplementary Table S1). Results obtained by searching the EST database
for231genesareshownassymbolsaftergenenames:Redcircle,genesexpressedpredominantlyinoocytes;bluecircle,genesexpressedpredominantlyin
preimplantation embryos (1-cell to blastocysts); pink square, genes expressed predominantly in testes or ovaries.
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not seem to be activated during Glis1-mediated iPSC formation, at
least based on the reported microarray data on day 5
38. Interestingly,
ZSCAN4waslistedintheirSupplementaryTableasoneof18factors
that can replace KLF4 for iPSC formation after screening 1437
human transcription factors; however, further characterization of
ZSCAN4 was not conducted
38. Taken together, Zscan4 is the first
reprogramming factor that can activate the expression of many
preimplantation-specific genes during the early phase of iPSC
formation.
One of the critical issues for the application of iPSCs to regenerat-
ive medicine is the potential cancer-risk due to the compromised
Figure 7 | Zscan4-dependent activation of preimplantation – and/or gonad-specific genes is mostly transient. (a) A heatmap showing expression
patterns of 201 genes (a subset of 231 genes) found in the NIA Gene Expression Atlas
35 (22 different adult organs/tissues and cultured cells, from left to
right:brain,cerebellum,eyes,skeletalmuscle,heart,bone,liver,kidney,bladder,skin,visceralfat,lung,smallintestine,largeintestine,stomach,placenta,
ovary,oocyte,testis,MEFcells,ESCs,andiPSCs).AmagnifiedpicturecanbefoundinSupplementaryFig.S6c.Bargraphsshowthegeneexpressionlevels
of two representative genes (Patl2 and D13Ertd608e) among these tissues. (b) A heatmap showing the expression patterns of 99 genes (a subset of 231
genes)found inthe GNFdatabase
36(62 different organs/tissues). Amagnified picture canbefound inSupplementary Fig. S6d. Bargraphs showthe gene
expression levels of two representative genes (Pramel6 and D5Ertd577e) among these tissues. (c) A summary diagram showing events occurring during
Zscan4-mediated iPSC formation.
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39.Inthissense, itis
conceivable that Zscan4 can help reprogram cells while preserving
genome stability. Zscan4 replaces the oncogene Myc in enhancing
the efficiency of iPSC formation with KOS factors. Interestingly,
unlike Myc and other iPSC-promoting conditions (e.g., repression
of P53 (reviewed in
40)), which stimulate the proliferation of MEFs
and destabilize genome integrity, Zscan4 represses the proliferation
of MEFs and ESCs. Furthermore, we have shown previously that
Zscan4 promotes genome stability and the maintenance of a normal
karyotype in ESCs
20. Indeed, iPSCs generated with ZMKOS factors
showed better karyotypes than iPSCs generated with MKOS factors.
Although more extensive analysis, including the comprehensive
genome sequencing approach
13–17, is required to draw any firm
conclusion, considering other anecdotal findings about the quality
of iPSCs generated with the aid of Zscan4, such as the successful
tetraploid complementation assay, these initial findings are pro-
mising. Future analyses of large numbers of iPSCs generated with
the aid of Zscan4 fortheir genomestability and possible tumorigeni-
city in chimeric animals will provide the definitive answers to these
important issues.
Methods
Plasmidvectorconstruction.ToconstructapCAG-Zscan4-ERT2plasmid,anentire
open reading frame (ORF: 506 a.a.) of a mouse Zscan4c gene
19 was fused with ERT2
(a mutated ligand-binding domain of the human estrogen receptor
28; 314 a.a.) and
cloned into the XhoI/NotI sites of a plasmid (pPyCAGBstXI-IP; a gift from
Dr. Hitoshi Niwa). The resultant plasmid vector (pCAG-Zscan4-ERT2) expresses a
Zscan4c-ERT2 fusion protein and a Puromycin-resistant protein driven by a strong
CAG promoter
29 (Fig. 1a). PiggyBac vectors (PB-TET-IRES- bgeo
21,22, PB-TET-
MKOS
21,22, and PB-CAG-rtTA
21,22) were purchased from Addgene.
GenerationofES-ZERTcellsandchimericmice.Allexperimentswereperformedin
accordance with the guidelines of the NIA/NIH Animal Care and Use Committee
(Approved Animal Study Proposal 311-LG-2012). V6.5 ESCs
41 derived from an F1
hybrid strain (C57BL/6 x 129/Sv) were purchased from Thermo Scientific Open
Biosystems. ESCs were cultured at 37uCi n5 %C O 2 in a complete ES medium:
DMEM, 15% FBS, 1000 U/ml LIF (ESGRO, Chemicon), 1 mM sodium pyruvate,
0.1 mM non-essential amino acids, 2 mM GlutaMAX, 0.1 mM b-mercaptoethanol,
penicillin, and streptomycin. V6.5 ESCs (5310
5 cells) in suspension were
cotransfected with 2 mg of a linearized pCAG-Zscan4-ERT2 vector and 0.4 mgo fa
PL452 vector
42 (a neomycin-resistant gene driven by a PGK promoter) using
Effectene (QIAGEN) according to the manufacturer’s protocol, and plated in
100 mm cell culture dishes. After selecting with G418 for 8 days, resulting ESC
colonieswerepicked,expanded,andfrozen.Subsequently,anES-ZERTcellclonewas
selected based on the results of genotyping, qPCR, and puromycin-resistance. ES-
ZERTcells(10-15cells)wereinjectedinto2NblastocystsandthentransferredtoE2.5
recipient females. After genotyping the pups, ZERT chimeric mice carrying pCAG-
Zscan4-ERT2 DNA were established.
MEF isolation. MEF-ZERT cells and MEF-WT cells were isolated from E13.5
embryos, which were obtained by crossing male ZERT mice to female ICR mice
(Figure 1a). MEF-WT (C57BL/6J x 129S6/SvEvTac) cells were isolated from E13.5
embryos, which were obtained by crossing between male 129SvEvTac mice and
female C57BL/6J mice. These cells were plated into a 10-cm plates in DMEM
supplemented with 10% FBS, 1 mM sodium pyruvate, 0.1 mM non-essential amino
acids, 2 mM GlutaMAX, 0.1 mM b-mercaptoethanol, penicillin and streptomycin.
PiggyBac-transfection and iPSC generation. iPSCs were generated as previously
reported
21,22 with some modifications. Briefly, MEFs were plated on gelatin-coated
6-well plates at a density of 1310
5 cells/well in complete ES medium. After a 24 h
incubation period, MEFs were transfected with 1.6 mg of each plasmid, which were
pCyL43
43 (Sanger institute), PB-CAG-rtTA and PB-TET-MKOS or -KOS with or
without PB-TET-Zscan4c or PB-TET-Zscan4cERT2, using Xfect (Clontech). After
24 h,cells werefedwith the complete ESmedium withDoxycycline (Dox: 1.5 mg/ml)
and with or without 200 nM 4-hydroxytamoxifen (Tmx). Colonies were picked after
12 days post-Dox induction and propagated as iPSCs in the complete ES medium
with Dox (1.5 mg/ml), until Dox-independency was observed in replicate wells.
Culture medium was changed every day.
Microarray Data Analysis. Expression profiling was carried out as described
37 using
whole-genome 60-mer oligonucleotide microarrays
44 (Agilent). Data analysis and
visualization were carried out by NIA Array Analysis Software
45. Heatmaps were
generated with MultiExperiment Viewer (Mev) v4.2
46. Heatmaps were produced by
the HCL (Hierarchical clustering) module of MeV4.2. All the microarray data have
been submitted to the public database GEO (accession number GSE28436, http://
www.ncbi.nlm.nih.gov/geo/).
Bisulfite sequencing. Sequencing data were analyzed using QUMA
47.
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